Today: 9 Fevereiro 2026
Subscribe
Search result

Phantom 4 RTK/feed/category/dji-mavic-3-pl- Page 142

Global Smartphone Market Share in 2025: Who Leads, Who Lags, and What Comes Next

Global Smartphone Market Share in 2025: Who Leads, Who Lags, and What Comes Next

Global smartphone shipments rose 6.4% in 2024 to 1.24 billion units, ending two years of decline, according to IDC. In Q3 2025, Samsung led with about 61 million units shipped, just ahead of Apple’s 59 million. IDC forecasts Apple will overtake Samsung for full-year shipments in 2025, a first in 14 years. Emerging markets and demand for AI and foldable phones are driving growth.
6 Dezembro 2025
····
Praxis Precision Medicines (PRAX) Stock Soars After Epilepsy Breakthrough and FDA Pre‑NDA Win

Praxis Precision Medicines (PRAX) Stock Soars After Epilepsy Breakthrough and FDA Pre‑NDA Win

Praxis Precision Medicines shares surged 30.5% to close at $247.99 on December 5, hitting a new 52-week high after positive epilepsy trial results and a favorable FDA pre-NDA meeting. The company’s market cap reached about $6.2 billion. PRAX stock has gained over 500% in three years but remains down 72% over five years. Wall Street sentiment is mostly positive, though some skepticism remains.
6 Dezembro 2025
·
LKQ Stock Outlook December 2025: S&P 500 Exit, Portfolio Shake-Up and Analyst Targets for NASDAQ: LKQ

LKQ Stock Outlook December 2025: S&P 500 Exit, Portfolio Shake-Up and Analyst Targets for NASDAQ: LKQ

LKQ Corporation will be removed from the S&P 500 and added to the S&P SmallCap 600 at the December 22, 2025 rebalance, following a 35% drop from its March high. Shares closed at $29.45 on December 5, near a 52-week low. The company trades at a trailing P/E of 8 and pays a 4% dividend yield. LKQ’s market cap stands at $7.4 billion.
6 Dezembro 2025
···
iRobot Stock (IRBT) Soars on Robotics Hype While Bankruptcy Risk Intensifies – Full Breakdown as of December 6, 2025

iRobot Stock (IRBT) Soars on Robotics Hype While Bankruptcy Risk Intensifies – Full Breakdown as of December 6, 2025

iRobot shares closed at $3.69 on December 5, up 22% with volume topping 145 million shares, after reports of a possible White House robotics initiative. SEC filings and lender disclosures warn of a high probability of bankruptcy, with shareholders potentially receiving no recovery. Short interest remains extremely high, fueling volatility. Market cap stands near $100–110 million, far below prior highs.
6 Dezembro 2025
·
Dollar Tree (DLTR) Stock Surges to 52-Week Highs on Q3 2025 Beat, Family Dollar Sale and a Wave of Six-Figure Shoppers

Dollar Tree (DLTR) Stock Surges to 52-Week Highs on Q3 2025 Beat, Family Dollar Sale and a Wave of Six-Figure Shoppers

Dollar Tree shares hit a 52-week high of $125.79 Friday, closing up 5.7% at $122.44 and nearly doubling from this year’s low. The company reported Q3 sales of $4.7–$4.75 billion and adjusted EPS of $1.21, both above estimates, and raised full-year guidance. Dollar Tree completed its $1 billion Family Dollar sale and saw a shift toward higher-income shoppers. The stock now trades above most analyst targets.
6 Dezembro 2025
··
Treasure Global (TGL) Stock Soars After 1‑for‑20 Reverse Split: 2026 Revenue Boom, OXI Wallet Catalyst and High-Risk Setup – Update for December 6, 2025

Treasure Global (TGL) Stock Soars After 1‑for‑20 Reverse Split: 2026 Revenue Boom, OXI Wallet Catalyst and High-Risk Setup – Update for December 6, 2025

Treasure Global Inc. (TGL) shares soared 276% to close at $25.44 after a 1-for-20 reverse stock split took effect December 5, 2025, with intraday highs near $29.39 and volume over 24 million shares. The company now projects over 500% revenue growth in 2026, driven by its OXI Wallet platform, UNIRWA token program, and the acquisition of Quarters Elite.
6 Dezembro 2025
·
Coca-Cola (KO) Stock in December 2025: Price, Dividend Power, AI Push and 2026 Forecasts

Coca-Cola (KO) Stock in December 2025: Price, Dividend Power, AI Push and 2026 Forecasts

Coca-Cola shares closed near $70 on December 5, 2025, about 5% below their 52-week high, with a market cap around $301–305 billion. Q3 net revenue rose 5% to $12.5 billion, with operating margin jumping to 32%. The stock’s five-year total return lags the S&P 500. The company faces a major lawsuit over ultra-processed foods and is investing in generative AI.
6 Dezembro 2025
··
Ripple, XRP and the New Payment Rails: Mastercard Pilot, $1B RLUSD Milestone and the 5‑Digit Price Debate

Ripple, XRP and the New Payment Rails: Mastercard Pilot, $1B RLUSD Milestone and the 5‑Digit Price Debate

Ripple’s RLUSD stablecoin reached a $1 billion milestone as the company expanded into corporate treasury with a $1 billion acquisition and appeared on stage with Mastercard. XRP community figure KING VALEX floated a speculative $10,000–$50,000 XRP price thesis tied to global financial infrastructure. Mainstream analysts remain skeptical of such high price targets. Ripple also launched a global brand campaign targeting institutions.
6 Dezembro 2025
···
SoundHound AI (SOUN) Stock Today: Latest News, Agentic AI Deals and Wall Street Forecasts – December 6, 2025

SoundHound AI (SOUN) Stock Today: Latest News, Agentic AI Deals and Wall Street Forecasts – December 6, 2025

SoundHound AI closed at $12.76 on December 5, 2025, with a market cap of $5.4 billion. Sassicaia Capital Advisers opened a new $2.87 million position, while several other institutions increased stakes. Analyst targets have risen, with Northland, Ladenburg Thalmann, and HC Wainwright all raising price targets, though WallStreetZen downgraded the stock to sell. Shares remain volatile, trading between $6.52 and $24.98 over the past year.
6 Dezembro 2025
··
Alibaba Group Holding Ltd – ADR (BABA) Stock: AI Boom, Pentagon Scrutiny and 2026 Forecasts After a Breakout 2025

Alibaba Group Holding Ltd – ADR (BABA) Stock: AI Boom, Pentagon Scrutiny and 2026 Forecasts After a Breakout 2025

Alibaba’s U.S.-listed shares closed at $158.32 on December 5, 2025, nearly doubling from their 52-week low but still 18% below the year’s high. The company reported Q2 revenue of 247.8 billion yuan, beating estimates, while net profit dropped 53% due to heavy AI and delivery investments. Washington’s national-security scrutiny and shareholder probes continue.
6 Dezembro 2025
·
Pfizer (PFE) Stock on December 6, 2025: Metsera Deal, 2025 Guidance and What Wall Street Expects Next

Pfizer (PFE) Stock on December 6, 2025: Metsera Deal, 2025 Guidance and What Wall Street Expects Next

Pfizer shares closed at $26.03 on December 5, 2025, up 1.28% and 24% above April’s low. The stock yields about 6.6% with an annualized dividend of $1.72 per share and has paid 347 consecutive quarterly dividends. Pfizer’s Q3 revenue fell 6% to $16.65 billion, but adjusted EPS beat expectations at $0.87. The stock trades at 8–9x forward earnings, below the market average.
6 Dezembro 2025
···
Gorilla Technology Group (GRRR) Stock: CVR Payout, Nobel Sustainability Nomination and a $1.4 Billion AI Bet – What Investors Need to Know Now

Gorilla Technology Group (GRRR) Stock: CVR Payout, Nobel Sustainability Nomination and a $1.4 Billion AI Bet – What Investors Need to Know Now

Gorilla Technology (NASDAQ: GRRR) closed at $14.97 on Dec. 5, 2025, with a market cap near $350–430 million and short interest at 12%. The company secured a $1.4 billion AI data-center contract in Southeast Asia and reported record revenue, but posted a $67 million net loss over the past year. GRRR shares are up over 150% in 12 months but down 20–25% in the past six months. Analyst opinions remain sharply split.
6 Dezembro 2025
·
Gilead Sciences Stock (GILD) Outlook 2026: Latest News, Trodelvy Data, Dividend and Analyst Forecasts

Gilead Sciences Stock (GILD) Outlook 2026: Latest News, Trodelvy Data, Dividend and Analyst Forecasts

Gilead Sciences shares closed at $121.22 on December 5, 2025, about 6% below their 52-week high. Third-quarter revenue rose 3% year-over-year to $7.8 billion, with HIV product sales up 4% to $5.3 billion. Veklury sales dropped as COVID cases fell. The company continues to invest in oncology and cell therapy despite near-term earnings pressure.
6 Dezembro 2025
···
Canopy Growth (CGC) Stock Outlook December 2025: Debt Prepayment, Lawsuit Pressure and a High‑Risk Turnaround

Canopy Growth (CGC) Stock Outlook December 2025: Debt Prepayment, Lawsuit Pressure and a High‑Risk Turnaround

Canopy Growth shares closed at $1.15 on December 5, down 4.96%, but remain up about 13–14% over the last 10 sessions. Q2 FY2026 net revenue rose 6% to C$66.7 million, with gross margin improving to 33%. Net loss narrowed sharply to C$1.6 million from C$131.6 million a year earlier. The company ended the quarter with C$298 million in cash, exceeding its total debt.
6 Dezembro 2025
··
SPDR Gold Trust (GLD) Surges 60% in 2025: Latest News, Fed Cut Bets and 2026 Gold Price Forecast

SPDR Gold Trust (GLD) Surges 60% in 2025: Latest News, Fed Cut Bets and 2026 Gold Price Forecast

SPDR Gold Shares (GLD) closed at $386.44 on December 5, down 0.2%, with assets over $140 billion and a net asset value of $390.26 per share. GLD has surged 59.6% year-to-date, outpacing the S&P 500, and posted a one-year Sharpe ratio of 3.07. The ETF tracks physical gold and does not pay dividends. Investors are watching the upcoming Federal Reserve meeting and gold price forecasts.
6 Dezembro 2025
··
Tilray Brands (TLRY) Stock in December 2025: Reverse Split, 90% Rally and What the Latest Forecasts Really Say

Tilray Brands (TLRY) Stock in December 2025: Reverse Split, 90% Rally and What the Latest Forecasts Really Say

Tilray Brands executed a 1-for-10 reverse stock split effective December 2, reducing outstanding shares from 1.16 billion to 116 million. Shares dropped over 20% after the split was scheduled, deepening year-to-date losses, but the stock remains up 90% over six months. Trading volume surged post-split. Analysts cite optimism over U.S. cannabis policy and Tilray’s first profit, but warn of regulatory risks.
7 Dezembro 2025
·
Novo Nordisk Stock (NVO) in December 2025: Alzheimer’s Failure, GLP‑1 Price Cuts and 2026 Turnaround Hopes

Novo Nordisk Stock (NVO) in December 2025: Alzheimer’s Failure, GLP‑1 Price Cuts and 2026 Turnaround Hopes

Novo Nordisk shares have dropped about 45% in 2025 and over 50% from their 2024 peak, following profit warnings, slower GLP-1 growth, and a failed Alzheimer’s trial. The stock now trades near $47.9, down sharply after the EVOKE and EVOKE+ studies showed no significant benefit for semaglutide in early Alzheimer’s. Revenue in Q3 2025 rose 5% to DKK 74.98 billion, missing analyst expectations.
7 Dezembro 2025
··
1 … 140 141 142 143 144 … 176
Go toTop